EVENS OCULAR ASSOCIATES
ActiveEVENS OCULAR ASSOCIATES has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.35M and a net result of €624k. Equity is growing by ~14.4% per year across the filed fiscal years. Its solvency ranks better than 54% of 2324 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
90
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability90▼-10
Solvency90▲+31
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €210k at 30 days acceptable
Liquidity ample (current ratio 3.5 against 1.16 in 2024; short-term debt: 14.6% and cash: 24.6% of total assets), and 35.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
64.7%
Return on assets
17.2%
Age of the figures
15 mo
neutral · Filed after the deadline
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 02-02-2026, 2 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
2 d late
2024
26 d late
2023
35 d early
2022
22 d late
2021
56 d late
2020
24 d late
2019
24 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close20-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€2.35M▲ 74.2%
2024 · €1.35M
2019: €997k
2020: €1.14M
2021: €1.31M
2022: €966k
2023: €1.33M
2024: €1.35M
2019 → 2025
Total assets
€3.64M▼ 7.2%
2024 · €3.92M
2019: €2.55M
2020: €3.41M
2021: €4.19M
2022: €3.98M
2023: €3.85M
2024: €3.92M
2019 → 2025
Net result
€624k▼ 49.0%
2024 · €1.22M
2019: €1.10M
2020: €450k
2021: €1.17M
2022: €1.03M
2023: €643k
2024: €1.22M
2019 → 2025
Working capital
€1.33M▲ 354%
2024 · €292k
2019: €287k
2020: €81k
2021: €308k
2022: €-357k
2023: €207k
2024: €292k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.31M-€966k▼ 26.1%€1.33M▲ 37.5%€1.35M▲ 1.8%€2.35M▲ 74.2%
Operating result€1.61M-€1.44M▼ 10.3%€884k▼ 38.7%€1.71M▲ 92.9%€1.41M▼ 17.2%
Net result€1.17M-€1.03M▼ 12.1%€643k▼ 37.3%€1.22M▲ 90.2%€624k▼ 49.0%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 17% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.64M
Fixed assets
€1.78M▼ 4.0%
Current assets
€1.86M▼ 10.1%
Equity and liabilities €3.64M
Equity
€2.35M▲ 74.2%
Debt
€1.29M▼ 50.0%
The debt ratio falls from 65.6% to 35.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€1.56M▼
2024 · €1.88M
Cash flow
€772k▼
2024 · €1.40M
Solvency
64.7%▲
2024 · 34.4%
Current ratio
3.50▲
2024 · 1.16
Quick ratio
3.37▲
2024 · 1.04
Debt / equity
0.55▼
2024 · 1.90
ROE
26.5%▼
2024 · 90.6%
ROA
17.2%▼
2024 · 31.2%
Interest coverage
101.33▲
2024 · 33.11
Debt
€1.29M▼
2024 · €2.57M
Debt ≤ 1 year
€531k▼
2024 · €1.77M
Debt > 1 year
€749k▼
2024 · €798k
Income taxes
€399k▼
2024 · €426k
Staff costs
€882k▲
2024 · €855k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€3.92M€3.64M▼
Fixed assets21/28€1.86M€1.78M▼
Intangible fixed assets21€51k€41k▼
Tangible fixed assets22/27€1.81M€1.74M▼
Land and buildings22€1.53M€1.44M▼
Plant, machinery and equipment23€163k€126k▼
Furniture and vehicles24€109k€173k▲
Current assets29/58€2.07M€1.86M▼
Stocks and contracts in progress3€221k€70k▼
Stocks30/36€221k€70k▼
Amounts receivable within one year40/41€435k€806k▲
Trade receivables40€154k€245k▲
Other amounts receivable41€282k€562k▲
Current investments50/53€900k-
Cash at bank and in hand54/58€507k€896k▲
Deferred charges and accrued income490/1€3k€85k▲
Equity and liabilities
Total equity and liabilities10/49€3.92M€3.64M▼
Equity10/15€1.35M€2.35M▲
Contributions10/11€30k€30k=
Reserves13€1.13M€1.51M▲
Non-distributable reserves130/1€6k€6k=
Reserves not available under the articles1311€6k€6k=
Tax-exempt reserves132€22k€384k▲
Distributable reserves133€1.10M€1.12M▲
Profit (loss) carried forward14€191k€815k▲
Amounts payable17/49€2.57M€1.29M▼
Amounts payable after more than one year17€798k€749k▼
Financial debts170/4€798k€749k▼
Amounts payable within one year42/48€1.77M€531k▼
Current portion of amounts payable after more than one year42€118k€166k▲
Trade debts44€245k€307k▲
Suppliers440/4€245k€307k▲
Taxes, remuneration and social security45€211k€58k▼
Taxes450/3€126k€10k▼
Remuneration and social security454/9€85k€49k▼
Other amounts payable47/48€1.20M-
Accrued charges and deferred income492/3-€6k
Income statement
Code20242025
Remuneration, social security and pensions62€855k€882k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€176k€147k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€153k
Other operating charges640/8€173k€9k▼
Non-recurring operating charges66A-€18k
Gross operating margin9900€2.91M€2.62M▼
Operating profit (loss)9901€1.71M€1.41M▼
Financial income75/76B€1€6k▲
Recurring financial income75€1€6k▲
Financial charges65/66B€57k€15k▼
Recurring financial charges65€57k€15k▼
Profit (loss) for the period before taxes9903€1.65M€1.40M▼
Transfer to deferred taxes680-€379k
Income taxes67/77€426k€399k▼
Profit (loss) for the period9904€1.22M€624k▼
Profit (loss) for the period to be appropriated9905€1.22M€624k▼
Appropriation of the result
Profit (loss) to be appropriated9906€1.39M€815k▼
Profit (loss) brought forward from the previous period14P€167k€191k▲
Profit to be distributed694/7€1.20M-
Return on contributions (dividend)694€1.20M-
Social balance
Average headcount (FTE)908714.216.4▲
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
02-02
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 2 days late
2025
30-06
Financial
Liquidity triplescurrent ratio 3.50
Current ratio from 1.16 to 3.50; short-term debt falls from €1.77M to €531k.
30-06
Financial
Equity above €2MEq €2.35M ▲74.2%
7 profitable years in a row build equity to €2.35M.
26-02
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 26 days late
2024
30-06
Financial
Highest result since 2019net €1.22M ▲90.2%
Operating result €1.71M, net result €1.22M, both a record.
2023
27-12
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
30-06
Financial
Equity above €1MEq €1.33M ▲37.5%
5 profitable years in a row build equity to €1.33M.
22-02
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 22 days late
2022
28-03
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 56 days late
2021
24-02
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 24 days late
2020
30-06
Financial
Weakest financial yearnet €450k ▼59.1%
Net result drops to €450k, the lowest in the series; recovery starts the following year.
30-06
Financial
Equity above €1MEq €1.14M ▲14.4%
2 profitable years in a row build equity to €1.14M.
24-02
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 24 days late
2019
31-01
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
31-01
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
24-02
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 24 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
7 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wemmel · 1 establishment unit since 2011
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kaasmarkt 971780 WemmelGround area
1,197 m²
Building footprint
774 m²
Volume, LiDAR
8,788 m³
2 parcels, Flanders · tallest building 14.9 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Focus Eye Clinic
since 20112.230.434.331
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 22005A0646/00V005 | Flanders | 781 m² | 1 · 509 m² | 14.4 m · 4 fl. |
| 22005A0601/00R003 | Flanders | 416 m² | 1 · 265 m² | 14.9 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2023 · 2 entries · 7,296 EUR awarded · 7,296 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 2,070 EUR | 2,070 EUR |
| 2022 | 1 | 5,226 EUR | 5,226 EUR |
Schemes
Vlaamse ondersteuningspremie (VOP) voor werkgevers (uitdovend stelsel)
Recognitions · licences · registrations
Legal Entity Identifier
254900UELMM0KKF3QL07
Similar companies · same sector, comparable size
DR.R.GOETHALS
BE 0881.800.373
Lievegem · Eq €2.35M
PNEUMOCARE
BE 0462.380.984
Gesves · Eq €2.35M
DOKTER CHRISTOPHE GEORGE
BE 0866.058.758
Zwevegem · Eq €2.34M
DR. MICHEL VAN LOO
BE 0879.546.411
Schilde · Eq €2.34M
L.S.G
BE 0521.733.603
Kalmthout · Eq €2.37M
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 4,249 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded29-12-2000
Fiscal year end30-06
Abbreviation NL
EVOCA
Activities, NACEBEL
85120
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 24 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.